Abstract
Background: Tuberculosis caused by Mycobacterium tuberculosis (MTB) is currently a major health concern due to its growing mortality rates around the world. The known anti-TB drugs although are available for the treatment but it produces adverse side effects on the human health and are also not very cost effective. Moreover, emergence of multidrug resistance (MDR) phenomenon has also compromised their activities.
Objective: Hence there is an urgent need to search novel drugs and compounds from natural sources having lesser side effects which have proved to be vital and widely used nowadays. Many recent studies have been established which show promising antimycobacterial activities against MTB.
Result: This review summarizes the various naturally occurring active compounds acting on different targets against MTB. Moreover, it also deals with the compounds having patent perspective.
Conclusion: Together, the article laid emphasis on reverting towards the natural compounds so that further work is carried out to exploit their therapeutic interventions.
Keywords: Mycobacterium tuberculosis, MDR, Natural compound, antimycobacterial activity, efflux pump, cell wall.
Recent Patents on Biotechnology
Title:Natural Compounds for Overcoming Multidrug Resistance in Mycobacteria
Volume: 10 Issue: 2
Author(s): Sharda Sharma, Saif Hameed and Zeeshan Fatima
Affiliation:
Keywords: Mycobacterium tuberculosis, MDR, Natural compound, antimycobacterial activity, efflux pump, cell wall.
Abstract: Background: Tuberculosis caused by Mycobacterium tuberculosis (MTB) is currently a major health concern due to its growing mortality rates around the world. The known anti-TB drugs although are available for the treatment but it produces adverse side effects on the human health and are also not very cost effective. Moreover, emergence of multidrug resistance (MDR) phenomenon has also compromised their activities.
Objective: Hence there is an urgent need to search novel drugs and compounds from natural sources having lesser side effects which have proved to be vital and widely used nowadays. Many recent studies have been established which show promising antimycobacterial activities against MTB.
Result: This review summarizes the various naturally occurring active compounds acting on different targets against MTB. Moreover, it also deals with the compounds having patent perspective.
Conclusion: Together, the article laid emphasis on reverting towards the natural compounds so that further work is carried out to exploit their therapeutic interventions.
Export Options
About this article
Cite this article as:
Sharma Sharda, Hameed Saif and Fatima Zeeshan, Natural Compounds for Overcoming Multidrug Resistance in Mycobacteria, Recent Patents on Biotechnology 2016; 10 (2) . https://dx.doi.org/10.2174/1872208310666160919122629
DOI https://dx.doi.org/10.2174/1872208310666160919122629 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies
Recent Patents on Anti-Cancer Drug Discovery Penicillium marneffei and its Pulmonary Involvements
Current Respiratory Medicine Reviews In-Silico Characterization of a Hypothetical Protein, Rv1288 of Mycobacterium tuberculosis Containing an Esterase Signature and an Uncommon LytE Domain
Current Computer-Aided Drug Design Stereochemistry at the Forefront in the Design and Discovery of Novel Anti-tuberculosis Agents
Current Topics in Medicinal Chemistry Chemokines and Defensins as HIV Suppressive Factors: An Evolving Story
Current Pharmaceutical Design Synthesis and Cytotoxicity of Amino-Pyrazole Derivatives with Preliminary SAR
Letters in Drug Design & Discovery HIF-1α Deficiency Perturbs T and B Cell Functions
Current Pharmaceutical Design In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler
Current Drug Delivery Mycobacterial DNA GyrB Inhibitors: Ligand Based Pharmacophore Modelling and In Vitro Enzyme Inhibition Studies
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Recent Trends in Library Design and Virtual Screening in Medicinal Chemistry and Drug Discovery)
Current Topics in Medicinal Chemistry Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Emerging Electrical Biosensors for Detecting Pathogens and Antimicrobial Susceptibility Tests
Current Organic Chemistry In-vitro Functionality of Clozapine Biphasic Release Minitablet Using Advanced Statistical Tools
Drug Delivery Letters Design and In Vitro Evaluation of Five Inhibitors of Mycobacterium Tuberculosis
Letters in Drug Design & Discovery Chylothorax
Current Respiratory Medicine Reviews Targeting Cytokines: Production and Characterization of Anti-TNF-α scFvs by Phage Display Technology
Current Pharmaceutical Design Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis. Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes
Current Enzyme Inhibition The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of Vaccines
Current Pharmaceutical Design Inhibitory MHC Class I Receptors on Myeloid Cells
Current Immunology Reviews (Discontinued) Marine Products with Anti-Protozoal Activity: A Review
Current Clinical Pharmacology